Mission Pharmacal launches new formulation for the treatment of kidney stones, UROC-K ® 15 mEq

UROC-K is considered the standard of care for patients with kidney stones, and we are pleased to offer a new best option for millions of Americans who suffer from kidney stones, said Neill Walsdorf, Jr., President of Mission Pharmacal. Continue to improve patient care is our tradition at the Mission, and we hope to help those suffering from kidney stones with this new K-UROC product. Continue reading